Personal information

Other IDs

Scopus Author ID: 57218259728

Activities

Collapse all

Works (3)

Screening of anti-inflammatory activity of 4.5- dihydroisoxazol-5-carboxamide (PAR-2 inhibitors) based on formaldehyde oedema model among white lab rats

Research Results in Pharmacology
2023 | Journal article
DOI: 10.18413/rrpharmacology.9.10061
EID:

2-s2.0-85182870743

Part of ISSN: 2658381X
Contributors: Korsakov, M.K.; Fedorov, V.N.; Smirnov, N.A.; Shetnev, A.A.; Leonova, O.V.; Volkhin, N.N.; Andreyev, A.I.
Source: Self-asserted source
Николай Смирнов via Scopus - Elsevier

Treatment of hepatitis induced by anti-tuberculosis drugs (experimental research)

Research Results in Pharmacology
2020 | Journal article
DOI: 10.3897/rrpharmacology.6.56453
EID:

2-s2.0-85092285134

Part of ISSN: 2658381X
Contributors: Fedorov, V.N.; Smirnov, N.A.; Vdovichenko, V.P.; Fedorova, T.B.; Kerbenev, E.E.; Petrovsky, A.K.
Source: Self-asserted source
Николай Смирнов via Scopus - Elsevier

Selank and semax as potential hepatoprotectors in medical treatment of tuberculosis

Research Results in Pharmacology
2019 | Journal article
DOI: 10.3897/RRPHARMACOLOGY.5.38769
EID:

2-s2.0-85088493841

Part of ISSN: 2658381X
Contributors: Petrovsky, A.K.; Smirnov, N.A.; Vdovichenko, V.P.; Fedorova, T.B.; Kerbenev, E.E.; Fedorov, V.N.
Source: Self-asserted source
Николай Смирнов via Scopus - Elsevier
How many people are using ORCID?